Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Platform Technologies Ease Scale-Up Pain
As Scale Gets Larger, the Need for Process Control Understanding Becomes Even More Critical
- Bioprocess scale-up is a time for rejoicing that a product has achieved some degree of success, however modest. It is also a time of great challenges, because in process industries, size definitely matters. “The scale-up process is a continuum in that the next step is often studied as soon ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.